{
  "docId": "019de513-e5f3-74ec-8589-3a25cd09ff3b",
  "docSlug": "84c69d87de6e9e74ab87b27f8216aaaa",
  "documentTitle": "Orthofix | Investor Presentation Deck | 22 slides",
  "authorId": "orthofix",
  "authorName": "Orthofix",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 19,
  "pageCount": 22,
  "prevPage": 18,
  "nextPage": 20,
  "slideType": "kpi_overview",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 10,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de513-e5f3-74ec-8589-3a25cd09ff3b/19",
  "deckHref": "/decks/019de513-e5f3-74ec-8589-3a25cd09ff3b",
  "deckJsonHref": "/decks/019de513-e5f3-74ec-8589-3a25cd09ff3b.json",
  "deckAnchorHref": "/decks/019de513-e5f3-74ec-8589-3a25cd09ff3b#slide-19",
  "components": [
    {
      "bbox": {
        "h": 0.58,
        "w": 0.35,
        "x": 0.58,
        "y": 0.22
      },
      "kind": "chart",
      "text": "REVENUE\n$121 M\n$112 M\n$125 M\n$106 M\n$118 M\n63%\n1%\n7%\n2%\n0%\nQ2 21\nQ3 21\nQ4 21\nQ1 22\nQ2 22",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "214af503-19d9-49d9-a36a-6c70f2512ad3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.48,
        "w": 0.46,
        "x": 0.07,
        "y": 0.22
      },
      "kind": "list",
      "text": "SECOND QUARTER 2022\n$118 million in net sales, flat on a constant currency basis versus the prior year\nGlobal Orthopedics net sales growth of 11% on a constant currency basis driven by new products and channel expansion\nExecuted partnership with CGBio to commercialize Novosis™ rhBMP-2 growth factor in the United States and Canada\nLimited launch of Virtuos™ Lyograft, a first-of-its-kind, shelf-stable and complete autograft substitute",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3d467e3c-699b-440c-91c9-1b10d6151384",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.33,
        "x": 0.59,
        "y": 0.87
      },
      "kind": "source-note",
      "text": "Percentages represent sales growth in constant currency vs. prior year\nQuarterly results are impacted by COVID and seasonality",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "533377a5-432a-49ca-a412-6e039bdf9bcf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.32,
        "x": 0.039,
        "y": 0.08
      },
      "kind": "title",
      "text": "Quarterly Highlights",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8916573e-aa9e-4f12-8d0a-6d5e8d2d1c6e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 20,
      "from": 17,
      "beatId": "a3a7ab6d-13f6-417f-a5b0-e93924a03005",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Financials",
      "beatSlug": "sequoia-pitch-financials",
      "evidence": "Financial overview is presented from page 17 to 20.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 21,
      "from": 7,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "2cf9ab67-b6ef-42b6-9761-335d1901b82e",
      "evidence": "The loop is visible in the narrative, emphasizing the importance of investing in innovation and growth to take market share.",
      "position": 0,
      "objective": "What are the costs of not investing in innovation and growth?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 22,
      "from": 1,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "8a643360-21a5-41f6-a5d6-67b2e4d6a621",
      "evidence": "The loop is visible in the narrative, highlighting the company's growth drivers and future prospects.",
      "position": 1,
      "objective": "Why is now the right time to invest in Orthofix?",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 0.6,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}